Hybrid epicardial-endocardial ablation for long-standing persistent atrial fibrillation: a subanalysis of the converge trial

HIGHLIGHTS

  • who: David B. DeLurgio MD from the StJoseph`s Hospital, Emory University, Atlanta, Georgia, Guy`s and St. Thomas` Foundation have published the article: Hybrid Epicardial-Endocardial Ablation for Long-Standing Persistent Atrial Fibrillation: A Subanalysis of the CONVERGE Trial, in the Journal: (JOURNAL)
  • what: To explore the impact of hybrid convergent ablation on LSPAF, for which there is a lack of effective treatments, the authors performed a post hoc analysis of the CONVERGE trial focused on the LSPAF subpopulation. One procedural difference in this study compared with the CONVERGE trial was that the hybrid . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?